Ticker

Gaithersburg, Maryland--(Newsfile Corp. - March 6, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early-stage drug development, today announced that it has entered into a securities purchase agreement with investors for the issuance and sale of 2,238,800 shares…

Gaithersburg, Maryland--(Newsfile Corp. - January 13, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), applauds the state of Utah which has become the first state in the United States to allow artificial intelligence systems to authorize prescription refills without direct physician involvement — a regulatory first that signals how AI is beginning to reduce…

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH - Get Free Report) shares dropped 6.3% during mid-day trading on Tuesday. The company traded as low as $1.71 and last traded at $1.77. Approximately 70,783 shares changed hands during mid-day trading, a decline of 57% from the average daily volume of 164,641 shares. The stock had previously closed